{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(3)"],"submitter":["Ebenfeld L"],"pubmed_abstract":["<h4>Background</h4>Previous studies provide evidence for the effectiveness of web-based interventions for panic disorder with and without agoraphobia. Smartphone-based technologies hold significant potential for further enhancing the accessibility and efficacy of such interventions.<h4>Objective</h4>This randomized controlled trial aims to evaluate the efficacy of a guided, hybrid web-based training program based on cognitive behavioral therapy for adults with symptoms of panic disorder.<h4>Methods</h4>Participants (N=92) with total scores in the Panic and Agoraphobia Scale ranging from 9 to 28 were recruited from the general population and allocated either to a hybrid intervention (GET.ON Panic) or to a wait-list control group. The primary outcome was the reduction in panic symptoms, as self-assessed using a web-based version of the Panic and Agoraphobia Scale.<h4>Results</h4>Analysis of covariance-based intention-to-treat analyses revealed a significantly stronger decrease in panic symptoms posttreatment (F=9.77; P=.002; Cohen d=0.66; 95% CI 0.24-1.08) in the intervention group than in the wait-list control group. Comparisons between groups of the follow-up measures at 3 and 6 months yielded even stronger effects (3-month follow-up: F=17.40, P<.001, Cohen d=0.89, 95% CI 0.46-1.31; 6-month follow-up: F=14.63, P<.001, Cohen d=0.81, 95% CI 0.38-1.24).<h4>Conclusions</h4>Hybrid web-based training programs may help reduce the symptoms of panic disorder and hence play an important role in improving health care for patients with this debilitating disorder.<h4>Trial registration</h4>German Clinical Trial Register DRKS00005223; https://tinyurl.com/f4zt5ran.<h4>International registered report identifier (irrid)</h4>RR2-10.1186/1745-6215-15-427."],"journal":["Journal of medical Internet research"],"pagination":["e20829"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7974752"],"repository":["biostudies-literature"],"pubmed_title":["Evaluating a Hybrid Web-Based Training Program for Panic Disorder and Agoraphobia: Randomized Controlled Trial."],"pmcid":["PMC7974752"],"pubmed_authors":["Berking M","Lehr D","Funk B","Ebenfeld L","Riper H","Ebert DD","Kleine Stegemann S"],"additional_accession":[]},"is_claimable":false,"name":"Evaluating a Hybrid Web-Based Training Program for Panic Disorder and Agoraphobia: Randomized Controlled Trial.","description":"<h4>Background</h4>Previous studies provide evidence for the effectiveness of web-based interventions for panic disorder with and without agoraphobia. Smartphone-based technologies hold significant potential for further enhancing the accessibility and efficacy of such interventions.<h4>Objective</h4>This randomized controlled trial aims to evaluate the efficacy of a guided, hybrid web-based training program based on cognitive behavioral therapy for adults with symptoms of panic disorder.<h4>Methods</h4>Participants (N=92) with total scores in the Panic and Agoraphobia Scale ranging from 9 to 28 were recruited from the general population and allocated either to a hybrid intervention (GET.ON Panic) or to a wait-list control group. The primary outcome was the reduction in panic symptoms, as self-assessed using a web-based version of the Panic and Agoraphobia Scale.<h4>Results</h4>Analysis of covariance-based intention-to-treat analyses revealed a significantly stronger decrease in panic symptoms posttreatment (F=9.77; P=.002; Cohen d=0.66; 95% CI 0.24-1.08) in the intervention group than in the wait-list control group. Comparisons between groups of the follow-up measures at 3 and 6 months yielded even stronger effects (3-month follow-up: F=17.40, P<.001, Cohen d=0.89, 95% CI 0.46-1.31; 6-month follow-up: F=14.63, P<.001, Cohen d=0.81, 95% CI 0.38-1.24).<h4>Conclusions</h4>Hybrid web-based training programs may help reduce the symptoms of panic disorder and hence play an important role in improving health care for patients with this debilitating disorder.<h4>Trial registration</h4>German Clinical Trial Register DRKS00005223; https://tinyurl.com/f4zt5ran.<h4>International registered report identifier (irrid)</h4>RR2-10.1186/1745-6215-15-427.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Mar","modification":"2025-04-18T16:03:18.169Z","creation":"2025-04-07T02:59:03.466Z"},"accession":"S-EPMC7974752","cross_references":{"pubmed":["33661121"],"doi":["10.2196/20829"]}}